Literature DB >> 28003985

Comparison of canaloplasty and trabeculectomy for open angle glaucoma: a Meta-analysis.

Zhong-Jing Lin1, Shuo Xu1, Shou-Yue Huang1, Xiao-Bin Zhang2, Yi-Sheng Zhong1.   

Abstract

AIM: To evaluate the advantage of canaloplasty compared to trabeculectomy for patients with open angle glaucoma.
METHODS: Potentially relevant studies were systematically searched using various databases from inception until December 2015. The outcome analyses performed automatically using Revman 5.3 included intraocular pressure reduction (IOPR), postoperative success rate, anti-glaucoma medications reduction and the incidence of adverse events.
RESULTS: We included four qualified studies incorporating a total of 215 eyes for quantitative synthesis. The weighted mean difference (WMD) of IOPR between canaloplasty and trabeculectomy from baseline to 12mo was -2.33 (95%CI: -4.00, -0.66). There was not significant improvement in the complete or qualified success rate (OR: 0.58, 95%CI: 0.26, 1.31; OR: 0.50, 95%CI: 0.10, 2.44, respectively). Similarly, no statistically significance was observed in anti-glaucoma mediations reduction (WMD: -0.54, 95%CI: -1.18, 0.09). Sensitivity analysis of the primary outcome estimate confirmed the stability of the Meta-analysis result.
CONCLUSION: Trabeculectomy seems to be more effective in lowering IOP up to 12mo when comparing with canaloplasty. Canaloplasty does not seem to be inferior to trabeculectomy considering the postoperative success rate or the number of postoperative anti-glaucoma medications. Meanwhile, it has an advantage of less bleb related complications.

Entities:  

Keywords:  Meta-analysis; canaloplasty; open angle glaucoma; trabeculectomy

Year:  2016        PMID: 28003985      PMCID: PMC5154998          DOI: 10.18240/ijo.2016.12.19

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  32 in total

1.  Canaloplasty in one eye compared with viscocanalostomy in the contralateral eye in patients with bilateral open-angle glaucoma.

Authors:  Norbert Josef Koerber
Journal:  J Glaucoma       Date:  2012-02       Impact factor: 2.503

2.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

3.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

Authors:  S H Downs; N Black
Journal:  J Epidemiol Community Health       Date:  1998-06       Impact factor: 3.710

4.  Canaloplasty: Three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucoma.

Authors:  Richard A Lewis; Kurt von Wolff; Manfred Tetz; Norbert Koerber; John R Kearney; Bradford J Shingleton; Thomas W Samuelson
Journal:  J Cataract Refract Surg       Date:  2011-04       Impact factor: 3.351

Review 5.  [Trabeculectomy versus canaloplasty].

Authors:  J Matlach; T Klink
Journal:  Ophthalmologe       Date:  2015-04       Impact factor: 1.059

Review 6.  Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis.

Authors:  Eliana Rulli; Elena Biagioli; Ivano Riva; Giovanni Gambirasio; Irene De Simone; Irene Floriani; Luciano Quaranta
Journal:  JAMA Ophthalmol       Date:  2013-12       Impact factor: 7.389

7.  Circumferential viscodilation and tensioning of Schlemm canal (canaloplasty) with temporal clear corneal phacoemulsification cataract surgery for open-angle glaucoma and visually significant cataract: one-year results.

Authors:  Bradford Shingleton; Manfred Tetz; Norbert Korber
Journal:  J Cataract Refract Surg       Date:  2008-03       Impact factor: 3.351

Review 8.  Antifibrotics and wound healing in glaucoma surgery.

Authors:  Paul J Lama; Robert D Fechtner
Journal:  Surv Ophthalmol       Date:  2003 May-Jun       Impact factor: 6.048

9.  [Circumferential viscocanalostomy with suture tensioning in Schlemm canal (canaloplasty)-one year experience].

Authors:  I Lopes-Cardoso; F Esteves; M Amorim; G Calvão-Santos; M L Freitas; J Salgado-Borges
Journal:  Arch Soc Esp Oftalmol       Date:  2013-04-17

10.  Trabeculectomy versus canaloplasty (TVC study) in the treatment of patients with open-angle glaucoma: a prospective randomized clinical trial.

Authors:  Juliane Matlach; Christine Dhillon; Johannes Hain; Günther Schlunck; Franz Grehn; Thomas Klink
Journal:  Acta Ophthalmol       Date:  2015-04-03       Impact factor: 3.761

View more
  6 in total

1.  Experimental circumferential canaloplasty with a new Schlemm canal microcatheter.

Authors:  Mao-Song Xie; Yong-Zheng Zheng; Li-Bin Huang; Guo-Xing Xu
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

2.  [Treatment success of canaloplasty and trabeculectomy by the same surgeon with the same level of experience in the long-term course].

Authors:  Lina Nassri; Niklas Plange; Friederike Lindemann; Hannah Schellhase; Peter Walter; David Kuerten
Journal:  Ophthalmologe       Date:  2020-10       Impact factor: 1.059

3.  A retrospective analysis of the use of loteprednol etabonate ophthalmic suspension 0.5% following canaloplasty.

Authors:  Mahmoud A Khaimi
Journal:  Clin Ophthalmol       Date:  2018-02-12

4.  Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma?

Authors:  Vivienne Dooling; Alexandra Lappas; Thomas Stefan Dietlein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-18       Impact factor: 3.535

Review 5.  Canaloplasty in the Treatment of Open-Angle Glaucoma: A Review of Patient Selection and Outcomes.

Authors:  Ivano Riva; Paolo Brusini; Francesco Oddone; Manuele Michelessi; Robert N Weinreb; Luciano Quaranta
Journal:  Adv Ther       Date:  2018-11-28       Impact factor: 3.845

6.  Needling and open filtering bleb revision after XEN-45 implantation-a retrospective outcome comparison.

Authors:  Stefan Steiner; Hemma Resch; Barbara Kiss; Daniel Buda; Clemens Vass
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-05-11       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.